L-Karnitin ve Alfa-Lipoik Asitin, HCT 116 +/+ ve -/- Kolon Kanser Hücre Serilerinin Proliferasyonu Üzerindeki Sinerjetik Etkileri

Cilt: 15 Sayı: 2 24 Haziran 2016
Aslı Koç , Arzu Zeynep Karabay , Tülin Özkan , Zeliha Büyükbingöl , Asuman Sunguroğlu , Fügen Aktan
PDF İndir
EN TR

Öz

It is an effective antioxidant molecule that exhibits free radical scavenging activity and it enhances antioxidant status in rats and exhibited anticancer properties. It has been shown that α-Lipoic acid is a very effective molecule against type 2 diabetes, atherosclerosis, inflammatory skin diseases, reperfusion arrhythmias and Parkinson’s disease and serves apoptotic action in different cancer cells. These molecules can display important roles in treatment of colon cancer. In this study, we examined the synergetic effects of α-lipoic acid and L-carnitine on HCT 116 +/+ and HCT 116 -/- colon cancer cell line. For this purpose, HCT 116 +/+ and -/- colon cancer cells were treated with L-carnitine and α-Lipoic acid for 24 hours and MTT assay and caspase 3 enzyme activity assay was conducted. α -Lipoic acid and L-carnitine alone or in combination decreased cell viability in HCT 116 +/+ and /- colon cancer cells and exhibited synergetic effect on the cell viability. Further studies must be conducted to find out the mechanism of their effects in cancer therapy

Anahtar Kelimeler

L-carnitine, α-lipoic acid, colon cancer

Kaynakça

  1. Behrend, L, Henderson, G., Zwacka, R.M. 2003. Reactive oxygen species in oncogenic transformation. Biochem Soc Trans, 31, 1441–1444.
  2. Bilska, A., Włodek, L.2005. Lipoic acid - the drug of the future?. Pharmacol Rep. 57(5), 570-7.
  3. Dozio, E., Ruscica, M., Passafaro, L., Dogliotti, G., Steffani, L., Marthyn, P., et al. 2010. The natural antioxidant alpha-lipoic acid induces p27(Kip1)-dependent cell cycle arrest and apoptosis in MCF-7 human breast cancer cells. Eur J Pharmacol. 641, 29–34.
  4. Dörsam, B., Göder, A., Seiwert, N., Kaina, B., Fahrer, J. 2015. Lipoic acid induces p53-independent cell death in colorectal cancer cells and potentiates the cytotoxicity of 5-fluorouracil. Arch Toxicol, (10), 1829-46.
  5. Feuerecker, B., Pirsig, S., Seidl, C., Aichler, M., Feuchtinger, A., Bruchelt, G., et al. 2012. Lipoic acid inhibits cell proliferation of tumor cells in vitro and in vivo. Cancer Biol Ther.13, 1425–35.
  6. Fujii, Y., Segawa, R., Kimura, M., Wang, L., Ishii, Y., Yamamoto, R., Morita, R., Mitsumori, K., Shibutani, M. 2013. Inhibitory effect of α-lipoic acid on thioacetamide-induced tumor promotion through suppression of inflammatory cell responses in a two-stage hepatocarcinogenesis model in rats.
  7. Chem Biol Interact, 205(2),108-18. Gülçin, I. 2006. Antioxidant and antiradical activities of L-carnitine. Life Sci, 78: 803–811.
  8. Hanahan, D., Weinberg Robert A. 2011. Hallmarks of cancer: the next generation. Cell,144 (5), 646–674.
  9. Huang,C.Y., Yu, L.C. 2015. Pathophysiological mechanisms of death resistance in colorectal carcinoma. World J Gastroenterol, 21(41), 11777–11792.
  10. Mantovani, G., Maccio, A., Madeddu, C., Mura, L., Massa, E., Gramignano, G., Lusso, M.R., Murgia, V., Camboni, P., Ferreli, L. 2003. Reactive oxygen species, antioxidant mechanisms, and serum cytokine levels in cancer patients: Impact of an antioxidant treatment. J Environ Pathol Toxicol Oncol, , 17–28. 9.

Kaynak Göster

APA
Koç, A., Karabay, A. Z., Özkan, T., Büyükbingöl, Z., Sunguroğlu, A., & Aktan, F. (2016). L-Karnitin ve Alfa-Lipoik Asitin, HCT 116 +/+ ve -/- Kolon Kanser Hücre Serilerinin Proliferasyonu Üzerindeki Sinerjetik Etkileri. Ankara Sağlık Hizmetleri Dergisi, 15(2), 1-8. https://doi.org/10.1501/Ashd_0000000114
AMA
1.Koç A, Karabay AZ, Özkan T, Büyükbingöl Z, Sunguroğlu A, Aktan F. L-Karnitin ve Alfa-Lipoik Asitin, HCT 116 +/+ ve -/- Kolon Kanser Hücre Serilerinin Proliferasyonu Üzerindeki Sinerjetik Etkileri. ASHD. 2016;15(2):1-8. doi:10.1501/Ashd_0000000114
Chicago
Koç, Aslı, Arzu Zeynep Karabay, Tülin Özkan, Zeliha Büyükbingöl, Asuman Sunguroğlu, ve Fügen Aktan. 2016. “L-Karnitin ve Alfa-Lipoik Asitin, HCT 116 +/+ ve -/- Kolon Kanser Hücre Serilerinin Proliferasyonu Üzerindeki Sinerjetik Etkileri”. Ankara Sağlık Hizmetleri Dergisi 15 (2): 1-8. https://doi.org/10.1501/Ashd_0000000114.
EndNote
Koç A, Karabay AZ, Özkan T, Büyükbingöl Z, Sunguroğlu A, Aktan F (01 Haziran 2016) L-Karnitin ve Alfa-Lipoik Asitin, HCT 116 +/+ ve -/- Kolon Kanser Hücre Serilerinin Proliferasyonu Üzerindeki Sinerjetik Etkileri. Ankara Sağlık Hizmetleri Dergisi 15 2 1–8.
IEEE
[1]A. Koç, A. Z. Karabay, T. Özkan, Z. Büyükbingöl, A. Sunguroğlu, ve F. Aktan, “L-Karnitin ve Alfa-Lipoik Asitin, HCT 116 +/+ ve -/- Kolon Kanser Hücre Serilerinin Proliferasyonu Üzerindeki Sinerjetik Etkileri”, ASHD, c. 15, sy 2, ss. 1–8, Haz. 2016, doi: 10.1501/Ashd_0000000114.
ISNAD
Koç, Aslı - Karabay, Arzu Zeynep - Özkan, Tülin - Büyükbingöl, Zeliha - Sunguroğlu, Asuman - Aktan, Fügen. “L-Karnitin ve Alfa-Lipoik Asitin, HCT 116 +/+ ve -/- Kolon Kanser Hücre Serilerinin Proliferasyonu Üzerindeki Sinerjetik Etkileri”. Ankara Sağlık Hizmetleri Dergisi 15/2 (01 Haziran 2016): 1-8. https://doi.org/10.1501/Ashd_0000000114.
JAMA
1.Koç A, Karabay AZ, Özkan T, Büyükbingöl Z, Sunguroğlu A, Aktan F. L-Karnitin ve Alfa-Lipoik Asitin, HCT 116 +/+ ve -/- Kolon Kanser Hücre Serilerinin Proliferasyonu Üzerindeki Sinerjetik Etkileri. ASHD. 2016;15:1–8.
MLA
Koç, Aslı, vd. “L-Karnitin ve Alfa-Lipoik Asitin, HCT 116 +/+ ve -/- Kolon Kanser Hücre Serilerinin Proliferasyonu Üzerindeki Sinerjetik Etkileri”. Ankara Sağlık Hizmetleri Dergisi, c. 15, sy 2, Haziran 2016, ss. 1-8, doi:10.1501/Ashd_0000000114.
Vancouver
1.Aslı Koç, Arzu Zeynep Karabay, Tülin Özkan, Zeliha Büyükbingöl, Asuman Sunguroğlu, Fügen Aktan. L-Karnitin ve Alfa-Lipoik Asitin, HCT 116 +/+ ve -/- Kolon Kanser Hücre Serilerinin Proliferasyonu Üzerindeki Sinerjetik Etkileri. ASHD. 01 Haziran 2016;15(2):1-8. doi:10.1501/Ashd_0000000114